CSPG4 and neoplasm: Control shRNA treated tumours had a significantly higher contrast ratio between the tumour and brain tissue on T1-wighted MRI images after contrast agent injection (Fig. 3H, p = 0.032), indicating greater vessel permeability compared to the vasculature from NG2 shRNA treated tumours.